'It's not funny, Mr. Shkreli': Congress grills drug exec

February 4, 2016 2:43 PM

16 0

Embattled drug entrepreneur Martin Shkreli, who vigorously defended his decision to hike the price of a life-saving drug from $13.50 to $750, was expected to go suddenly silent Thursday at a Congressional committee.

As the hearing began, members of Congress launched into fiery lectures directed at Shkreli, whose previous company, Turing Pharmaceuticals, came under scrutiny when it raised the price of Daraprim.

Also read: Fresh Off Time Warner Deal, AT&T Plans Aggressive Content Strategy

Read more

To category page